The murine pan T cell marker CD96 is an adhesion receptor for CD155 and nectin-1

被引:79
|
作者
Seth, S.
Maier, M. K.
Qiu, Q.
Ravens, I.
Kremmer, E.
Foerster, R.
Bernhardt, G.
机构
[1] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany
[2] GSF, Inst Mol Immunol, D-81377 Munich, Germany
关键词
CD155; CD96; nectin-1; antibody; monoclonal antibody; expression; adhesion; T cells;
D O I
10.1016/j.bbrc.2007.10.102
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The CD 155 ligand CD96 is an immunoglobulin-like protein tentatively allocated to the repertoire of human NK receptors. We report here that the CD96/CD 155-interaction is preserved between man and mouse although both receptors are only moderately conserved in amino acid sequence. Moreover, murine CD96 (mCD96) binds to nectin-1, a receptor related to CD155. Applying newly generated monoclonal antibodies specifically recognizing mCD96, an expression profile is revealed resembling closely that of human CD96 (hCD96) on cells of hematopoietic origin. A panel of anti-mCD96 but also recently established anti-mCD155 antibodies effectively prevents formation of CD96/CD 155-complexes. This was exploited to demonstrate that the only available receptor for mCD96 present on thymocytes is mCD155. Moreover, T cell adhesion to insect cells expressing mCD 155 is blocked by these antibodies depending on the T cell subtype. These results suggest a function of the CD96/CD155-adhesion system in T cell biology. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:959 / 965
页数:7
相关论文
共 50 条
  • [41] Blocking TIGIT/CD155 signalling reverses CD8+ T cell exhaustion and enhances the antitumor activity in cervical cancer
    Lu Liu
    Aihong Wang
    Xiaoli Liu
    Sai Han
    Yu Sun
    Junhua Zhang
    Lingyu Guo
    Youzhong Zhang
    Journal of Translational Medicine, 20
  • [42] Blocking TIGIT/CD155 signalling reverses CD8+ T cell exhaustion and enhances the antitumor activity in cervical cancer
    Liu, Lu
    Wang, Aihong
    Liu, Xiaoli
    Han, Sai
    Sun, Yu
    Zhang, Junhua
    Guo, Lingyu
    Zhang, Youzhong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [43] Combined inhibition of PD1 and CD96 checkpoints improves survival in a resectable murine model of pancreatic cancer
    Brooks, J.
    Fleischmann-Mundt, B.
    Woller, N.
    Manns, M. P.
    Kubicka, S.
    Guerlevik, E.
    Kuehnel, F.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S189 - S189
  • [44] Bispecific antibody targeting CD155 mediates T-cell immunotherapy against human gynecological malignancies
    Li Ma
    Juan Ma
    Dingqing Feng
    Xin Xue
    Investigational New Drugs, 2025, 43 (2) : 318 - 327
  • [45] CD155 Regulates Regulatory T Cell Population and Attenuates Acute Graft-Versus-Host Disease
    Kanaya, Minoru
    Shibuya, Kazuko
    Abe, Fumie
    Teshima, Takanori
    Shibuya, Akira
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S335 - S335
  • [46] BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to improve PD-1 response in cancer
    Feng, Mei
    Wu, Zhongen
    Zhou, Yan
    Wei, Zhuang
    Tian, Enming
    Mei, Shenglin
    Zhu, Yuanyuan
    Liu, Chenglong
    He, Fenglian
    Li, Huiyu
    Xie, Cao
    Jin, Joy
    Dong, Jibin
    Yang, Dehua
    Yu, Ker
    Qian, Junbin
    Lambrechts, Diether
    Wang, Ming-Wei
    Zhu, Di
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [47] BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to improve PD-1 response in cancer
    Mei Feng
    Zhongen Wu
    Yan Zhou
    Zhuang Wei
    Enming Tian
    Shenglin Mei
    Yuanyuan Zhu
    Chenglong Liu
    Fenglian He
    Huiyu Li
    Cao Xie
    Joy Jin
    Jibin Dong
    Dehua Yang
    Ker Yu
    Junbin Qian
    Diether Lambrechts
    Ming-Wei Wang
    Di Zhu
    Signal Transduction and Targeted Therapy, 6
  • [48] Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: Evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)
    Pende, D
    Spaggiari, GM
    Marcenaro, S
    Martini, S
    Rivera, P
    Capobianco, A
    Falco, M
    Lanino, E
    Pierri, I
    Zambello, R
    Bacigalupo, A
    Mingari, MC
    Moretta, A
    Moretta, L
    BLOOD, 2005, 105 (05) : 2066 - 2073
  • [49] Long Noncoding RNA KCNQ1OT1 is a Prognostic Biomarker and mediates CD8+ T cell exhaustion by regulating CD155 Expression in Colorectal Cancer
    Lin, Zheng-bin
    Long, Pei
    Zhao, Zhan
    Zhang, Yi-ran
    Chu, Xiao-dong
    Zhao, Xiao-xu
    Ding, Hui
    Huan, Song-wei
    Pan, Yun-long
    Pan, Jing-hua
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (07): : 1757 - 1768
  • [50] Resistance to immunotherapy is associated with high parenchymal PD1+CD8+/CD8+T cells (PD1tR) driven by tumour CD155
    de Oliveira, A. Lepletier
    Madore, J.
    O'donnell, S.
    Johnston, R. L.
    Eastgate, M.
    Mallardo, D.
    Ascierto, P. A.
    Massi, D.
    Merelli, B.
    Mandala, M.
    Wilmott, J. S.
    Bald, T.
    Stagg, J.
    Routy, B.
    Long, G. V.
    Scolyer, R. A.
    Waddell, N.
    Dougall, W. C.
    Teng, M. W. L.
    Smyth, M.
    ANNALS OF ONCOLOGY, 2019, 30